Patient-led research groups lead biobanks, research funds, and biotechs across 8,000 genetic diseases. We build modern infrastructure that makes it easy for groups to centralize, partner, and broadcast their research to academics, drug developers, donors, and more. We believe that precision drug development will be scaled to all through the efforts of our loved ones. Earlier, we built Librarey.com - a crowdsourced search platform for rare disease and disability resources. Everything we build is co-designed with patient families. Backed by Character VC, Drive Capital, PharmStars, and Noah.
| Website | https://comend.io |
| Employees | 9 (2 on RocketReach) |
| Founded | 2023 |
| Industry | Biotechnology Research |
| Keywords | Patient Advocacy, Patient Engagement, Patient Support Groups, Patient Empowerment, Life Science Research, Patient Communities, Clinical Trials, Medical Research Funding, Health Advocacy, Research Collaboration, Healthcare Technology, Philanthropic Funding, Medical Technology, Patient Data, Nonprofit Technology, Rare Disease Research, Drug Discovery, Digital Health, Healthcare Software |
Looking for a particular Comend employee's phone or email?
Albert W is the Co-founder, CEO of Comend.
2 people are employed at Comend.
Comend is based in Toronto, Ontario.